[
  {
    "ID": "17393_36-2021_NCT04341571",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1. Does the patient have prediabetes according to ADA criteria?\n\nYes, the patient has fasting blood glucose levels between 100-125 mg\/dL, which meets the criteria for prediabetes.\n\n#2. Is the patient's age between 31 and 60 years old?\n\nYes, the patient is 32 years old, which is within the inclusion criteria age range.\n\n#3. Does the patient have a body mass index (BMI) between 25 and 34.9 kg\/m2?\n\nYes, the patient has a BMI of 31.5 kg\/m2, which is within the inclusion criteria range.\n\n#4. Has the patient been stable in weight for at least the previous last 3 months (weight variation less than 10%)?\n\nYes, the patient has been stable in weight for at least the previous last 3 months, with a weight variation of less than 10%.\n\n#5. Is the patient willing and able to take pills and sign an informed consent?\n\nYes, the patient is willing and able to take pills and sign an informed consent.\n\nBased on the criteria above, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.",
    "PROBA": 0.9262146058
  },
  {
    "ID": "35756_75-2021_NCT04214509",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1. Does the patient have Parkinson's disease?\n\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2. Is the patient older than 18 years old?\n\nYes, the patient is an adult.\n\n#3. Is the patient a family member of a participant with LRRK2 parkinsonism or a member of a high-risk population with an early PD onset?\n\nNo, the patient does not meet this criterion.\n\n#4. Is the patient unable to provide informed consent?\n\nNo, the patient is able to provide informed consent.\n\nBased on the criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.",
    "PROBA": 0.9157779932
  },
  {
    "ID": "5261_12-2021_NCT00723801",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient have Marfan syndrome?\n\nYes, the patient has a known diagnosis of Marfan syndrome.\n\n#2: Is the patient at least 25 years old?\n\nYes, the patient is 34 years old, which is greater than 25 years old.\n\n#3: Does the patient have clinical Marfan syndrome?\n\nYes, the patient has a known diagnosis of Marfan syndrome and is symptomatic.\n\n#4: Are there any exclusion criteria that apply to the patient?\n\nNo, the patient does not have any of the exclusion criteria listed (previous aortic or cardiac surgery, pregnancy, renal insufficiency, or medication intolerance).\n\nTherefore, based on the inclusion and exclusion criteria, the patient would be eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.",
    "PROBA": 0.9276515454
  },
  {
    "ID": "6586_15-2021_NCT00230971",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1. Does the patient have a clinical diagnosis of complicated intra-abdominal infection that requires surgery within 24 hours?\n\nYes, the patient has a clinical diagnosis of complicated intra-abdominal infection (pancreatic adenocarcinoma at the head of pancreas and splenic flecture\/pancreatic tail mass) that requires surgery within 24 hours.\n\n#2. Does the patient have fever plus other symptoms such as nausea, vomiting, abdominal pain?\n\nYes, the patient has fever (38.5\u00b0C) and other symptoms such as nausea, vomiting, and abdominal pain.\n\n#3. Does the patient have any of the exclusion criteria?\n\nNo, the patient does not have any of the exclusion criteria (cancer, medicines that suppress the immune system, dialysis).\n\nTherefore, based on the inclusion and exclusion criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.",
    "PROBA": 0.9350157981
  },
  {
    "ID": "14027_30-2021_NCT01551498",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient meet the inclusion criteria?\n\nYes, the patient meets the inclusion criteria of being an adult aged 18-70 years old and having positive antibodies against thyroid peroxidase, which is consistent with a diagnosis of Hashimoto's thyroiditis.\n\n#2: Does the patient meet the exclusion criteria?\n\nNo, the patient does not meet the exclusion criteria of being a current smoker or smokeless tobacco user, taking systemic glucocorticoids, interferon-alpha, anti-CD20 antibody, or anti-CTLA-4 antibody, or taking any medication for treatment of autoimmune thyroiditis other than L-thyroxine or equivalent.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.",
    "PROBA": 0.9390876381
  },
  {
    "ID": "24993_53-2021_NCT00724178",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1. Does the patient have HIV infection?\n\nNo, the patient does not have HIV infection.\n\n#2. Is the patient able and willing to provide informed consent\/assent?\n\nYes, the patient is able and willing to provide informed consent\/assent.\n\n#3. Does the patient have a history of atraumatic fractures, known renal or liver disease, known malabsorption syndrome, or inflammatory bowel disease?\n\nNo, the patient does not have any of these conditions.\n\n#4. Is the patient currently using corticosteroids, excluding inhaled steroids?\n\nNo, the patient is not currently using corticosteroids.\n\n#5. Is the patient currently smoking or consuming alcohol-containing beverages?\n\nNo, the patient does not currently smoke or consume alcohol-containing beverages.\n\nBased on the criteria listed in the clinical trial, the patient is not eligible for the study. Therefore, the answer is:\n\nB: Excluded.",
    "PROBA": 0.9316997761
  },
  {
    "ID": "6590_15-2021_NCT00317265",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Is the patient eligible for surgical myocardial revascularization?\n\nYes, the patient is eligible for surgical myocardial revascularization.\n\n#2: Is the patient's age 70 years or less?\n\nNo, the patient's age is 70 years or more.\n\n#3: Does the patient have triple vessel coronary disease with significant coronary artery stenosis?\n\nYes, the patient has triple vessel coronary disease with significant coronary artery stenosis.\n\n#4: Does the patient have stable angina pectoris or unstable angina pectoris?\n\nYes, the patient has unstable angina pectoris.\n\n#5: Is the patient willing and able to give informed consent?\n\nNo, the patient is not willing and able to give informed consent because they have a history of recent (< 2 weeks) cerebrovascular event (TIA, RIND, stroke).\n\nTherefore, the patient is not eligible for the clinical trial.",
    "PROBA": 0.9375327369
  },
  {
    "ID": "33436_71-2021_NCT00502658",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Age\n\nThe patient is 34 years old, which is within the age range of 18-65 years old for the clinical trial. Therefore, the patient meets the age inclusion criterion.\n\n#2: BMI\n\nThe patient has a BMI of 41.5, which is within the range of 25-35 kg\/m2 for the clinical trial. Therefore, the patient meets the BMI inclusion criterion.\n\n#3: No current use of weight loss medication or supplements\n\nThe patient is not currently taking any weight loss medication or supplements, which meets the exclusion criterion.\n\n#4: No history of serious heart problems\n\nThe patient does not have a history of serious heart problems, which meets the exclusion criterion.\n\n#5: No diagnosed diabetes\n\nThe patient does not have diagnosed diabetes, which meets the exclusion criterion.\n\n#6: No known history of gastrointestinal diseases\n\nThe patient does not have a known history of gastrointestinal diseases, which meets the exclusion criterion.\n\n#7: No history of stroke or seizure activity\n\nThe patient does not have a history of stroke or seizure activity, which meets the exclusion criterion.\n\n#8: No history of uncontrolled hypertension\n\nThe patient's blood pressure is within the normal range, which meets the exclusion criterion.\n\n#9: No known allergies to supplements\n\nThe patient does not have any known allergies to supplements, which meets the exclusion criterion.\n\n#10: No known history of eating disorder\n\nThe patient does not have a known history of eating disorder, which meets the exclusion criterion.\n\n#11: No known severe swallowing disorders\n\nThe patient does not have a known severe swallowing disorder, which meets the exclusion criterion.\n\n#12: Not pregnant or breast-feeding\n\nThe patient is not pregnant or breast-feeding, which meets the exclusion criterion.\n\nBased on the above criteria, the patient is eligible for the",
    "PROBA": 0.957809642
  },
  {
    "ID": "33632_71-2021_NCT02069626",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "import { Assistant } from '..\/assistant';\n\ndescribe('Assistant', () => {\n  const assistant = new Assistant();\n\n  it('should evaluate patient eligibility for clinical trial', () => {\n    const patientNote = 'The patient is a 34-year-old obese woman who comes to the clinic with weight concerns. She is 165 cm tall, and her weight is 113 kg (BMI: 41.5). In the past, she unsuccessfully used antiobesity agents and appetite suppressants. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher. She is married for 5 years. She doesn\\'t use any contraceptive methods for the past 4 months and she had no prior pregnancies. She rarely exercises and movement seems to be hard for her. She is not able to complete the four-square step test in less than 15 seconds. She does not smoke or use any drugs. Her BP: 130\/80, HR: 195\/min and her BMI is: 41.54. Her lab results: FBS: 98 mg\/dl TG: 150 mg\/dl Cholesterol: 180 mg\/dl LDL: 90 mg\/dl HDL: 35 mg\/dl She is considering a laparoscopic gastric bypass.';\n    const clinicalTrial = {\n      title: 'The Effect of Compression Time for Secure Stapling With a Linear Stapler in Laparoscopic Gastric Bypass Surgery',\n      summary: 'Bleeding from the staple line is a complication of linear stapling. After clamping, a short period after firing of the laparoscopic linear stapler is recommended. That is, the clinician should continue to press the tissue between the prongs of the device to achieve adequate hemostasis at the staple line. The significance of the waiting period for hemostasis at the staple line has not been empirically clarified in",
    "PROBA": 0.9819168063
  },
  {
    "ID": "35347_75-2021_NCT00494689",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient have cerebral ischemia with or without hydrocephalus?\n\n#2: Does the patient have gait apraxia?\n\n#3: Does the patient have any other conditions that contribute to walking difficulty (e.g. bad knees, spondylosis, parkinson's, paralytic strokes)?\n\nPlease answer each question with either \"yes\" or \"no\" before moving on to the next question.",
    "PROBA": 0.8852432934
  },
  {
    "ID": "35568_75-2021_NCT02703844",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient have Parkinson's disease?\n\n#2: Does the patient have limitations to Activities of Daily Life?\n\n#3: Is the patient capable of consenting to the study?\n\n#4: Does the patient have a good level of spoken English?\n\nPlease answer each question with either \"yes\" or \"no\" before moving on to the next question.",
    "PROBA": 0.8564562022
  },
  {
    "ID": "17012_36-2021_NCT01252875",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient have a recent ischemic stroke or TIA?\n\nYes, the patient has a recent TIA (less than 15 days) with documented ischemic lesion on CT\/MRI imaging. Therefore, the patient meets the inclusion criterion #1.\n\n#2: Does the patient have atherosclerotic stenosis in carotid artery, aortic arch, or other brain arteries?\n\nYes, the patient has documented atherosclerotic stenosis in carotid artery (based on the results of Duplex echography, CTA, MRA, or X-ray angiography). Therefore, the patient meets the inclusion criterion #2.\n\n#3: Is the patient aged >18 years and has a Rankin score \u2264 4?\n\nYes, the patient is aged 32 years and has a Rankin score of 4, which meets the inclusion criterion #3.\n\n#4: Is the patient or a legal representative signs consent?\n\nYes, the patient or a legal representative signs consent, which meets the inclusion criterion #4.\n\n#5: Is the patient affiliated to social security system?\n\nYes, the patient is affiliated to social security system, which meets the inclusion criterion #5.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.",
    "PROBA": 0.9360321121
  },
  {
    "ID": "35669_75-2021_NCT03585257",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1. Age >18 years\n\nYes, the patient is 55 years old, which is above the age of 18.\n\n#2. Cirrhosis defined by any one of the following\n\nYes, the patient has cirrhosis as defined by the presence of varices in a patient with chronic liver disease.\n\n#3. Prior HE controlled on standard of care therapy defined as lactulose or rifaximin for at least 2 months prior to enrollment.\n\nYes, the patient has had prior overt HE that was controlled on standard of care therapy with lactulose and rifaximin for at least 2 months prior to enrollment.\n\n#4. Serum albumin <4 gm\/dl\n\nYes, the patient has a serum albumin level of <4 gm\/dl.\n\n#5. Cognitive impairment on any of the three testing strategies for HE\n\nYes, the patient has cognitive impairment on the Psychometric hepatic encephalopathy score (PHES) with an aggregate score of <-4SD based on norms published in Allampati et al located at the website www.encephalapp.com.\n\nBased on the criteria above, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: Eligible.",
    "PROBA": 0.9251745981
  },
  {
    "ID": "6962_15-2021_NCT03557216",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "import { isEligible } from '..\/utils\/eligibility-utils';\n\nconst patientNote = {\n  age: 70,\n  gender: 'Female',\n  medicalHistory: [\n    {\n      name: 'Coronary artery disease',\n      date: '2018-02-10',\n    },\n    {\n      name: 'Mitral valve prolapse',\n      date: '2018-02-10',\n    },\n    {\n      name: 'Atrial fibrillation',\n      date: '2018-02-10',\n    },\n    {\n      name: 'Hyperlipemia',\n      date: '2018-02-10',\n    },\n    {\n      name: 'Hypertension',\n      date: '2018-02-10',\n    },\n    {\n      name: 'Chronic kidney disease',\n      date: '2018-02-10',\n    },\n    {\n      name: 'Hypothyroidism',\n      date: '2018-02-10',\n    },\n    {\n      name: 'Anemia',\n      date: '2018-02-10',\n    },\n  ],\n  currentCondition: {\n    name: 'Acute diverticulitis',\n    date: '2023-03-10',\n  },\n};\n\nconst clinicalTrial = {\n  title: 'Acute Diverticulitis and Advanced Colonic Neoplasia. When to Perform Colonoscopy (ADACOLON Study)',\n  summary: 'This study evaluates the prevalence of advanced colonic neoplasia (ACN) in acute diverticulitis. A sub-analysis of complicated and uncomplicated acute diverticulitis will be made in order to determine whether there are differences of advanced colonic neoplasia (ANC) prevalence in both groups and to assess if a colonoscopy is necessary.',\n  inclusionCriteria: [\n    {\n     ",
    "PROBA": 0.9614689618
  },
  {
    "ID": "30600_65-2021_NCT01512654",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Age\nThe patient is 25 years old, which is within the inclusion criteria age range of 18 to 70 years old. Therefore, the patient meets the age criterion.\n\n#2: Diagnosis\nThe patient has been diagnosed with type 1 diabetes for at least one year prior to study entry, which meets the inclusion criterion of being diagnosed with type 1 or type 2 diabetes for at least one year.\n\n#3: Treatment\nThe patient is treated by a basal-bolus insulin therapy using an external pump or multiple-daily injections, which meets the inclusion criterion of being treated by a basal-bolus insulin therapy.\n\n#4: HbA1c\nThe patient's HbA1c is between 7.5% and 10.5%, which meets the inclusion criterion of having a stable diabetes with a HbA1c between \u2265 7.5 % and < 10.5 % with no keto-acidosis for the previous 6 months.\n\n#5: BMI\nThe patient's BMI is lower than 35 Kg\/m\u00b2, which meets the inclusion criterion of having a BMI lower than 35 Kg\/m\u00b2.\n\n#6: Willingness\nThe patient is willing to undergo all study procedures, which meets the inclusion criterion of being willing to undergo all study procedures.\n\n#7: Affiliation\nThe patient is affiliated or beneficiary of a social medical insurance, which meets the inclusion criterion of being affiliated or beneficiary of a social medical insurance.\n\n#8: Informed Consent\nThe patient has signed informed consent form prior to study entry, which meets the inclusion criterion of having signed informed consent form prior to study entry.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.",
    "PROBA": 0.9566362216
  },
  {
    "ID": "14298_30-2021_NCT04754607",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient have Hashimoto's thyroiditis?\n\nYes, the patient has been diagnosed with Hashimoto's thyroiditis.\n\n#2: Is the patient between the ages of 18-65?\n\nYes, the patient is 33 years old, which is within the age range of 18-65.\n\n#3: Did the patient apply to the Kosuyolu Istanbul Medipol Hospital Endocrinology and Metabolic Diseases Clinic between 2020-2021 and receive a diagnosis of Hashimoto's thyroiditis from a specialist physician?\n\nNo, the patient was diagnosed with Hashimoto's thyroiditis by a specialist physician at another hospital.\n\n#4: Is the patient currently taking Levothyroxine?\n\nYes, the patient is currently taking 250 mcg of Levothyroxine per day.\n\n#5: Does the patient have any of the exclusion criteria?\n\nNo, the patient does not have any of the exclusion criteria (acute infection, use of immunosuppressants, immunostimulants, or drugs that interfere with the production, transport, and metabolism of thyroid hormones, thyroid nodules, tracheal stenosis, serious illness, history of exposure to ionizing radiation and\/or neoplasia in the cervical region, malignancy and a history of thyroid surgery, hypothyroidism caused by postpartum thyroiditis, pregnancy, or breastfeeding period).\n\nBased on the answers to these questions, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: Eligible.",
    "PROBA": 0.9442942991
  },
  {
    "ID": "35595_75-2021_NCT02894567",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient have Parkinson's disease or Essential Tremor?\n\n#2: Does the patient meet the age requirements?\n\n#3: Does the patient have a history of at least 30% improvement on the UPDRS therapy in L-dopa?\n\n#4: Is the patient experiencing functional disability due to tremor that was not adequately controlled by medication for at least 3 months prior to implant?\n\n#5: Does the patient have any exclusion criteria?\n\nPlease select one of the options below based on the patient's information:\n\nA: Eligible\nB: Excluded\nC: Irrelevant\n\nPlease select one of the options below based on the patient's information:\n\nA: Eligible\nB: Excluded\nC: Irrelevant",
    "PROBA": 0.9028131352
  },
  {
    "ID": "35764_75-2021_NCT04236843",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1. Does the patient have IBS?\n\n#2. Has the patient been investigated to exclude other gastrointestinal organic causes?\n\n#3. Does the patient have moderate-to-severe IBS symptoms?\n\n#4. Is the patient pregnant or lactating?\n\n#5. Has the patient used antibiotics or probiotics within the past month?\n\n#6. Is the patient immunocompromised?\n\n#7. Does the patient have co-morbidities such as kidney failure or chronic heart disease?\n\n#8. Does the patient have systemic diseases such as diabetes?\n\n#9. Does the patient have serious psychiatric disorders or drug abuse?\n\nPlease answer the questions with the following options:\nA. Yes\nB. No\nC. Not relevant\n\nPlease provide your answers and I will determine the patient's eligibility for the clinical trial based on the inclusion and exclusion criteria.",
    "PROBA": 0.9116774175
  },
  {
    "ID": "35827_75-2021_NCT04810104",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient meet the inclusion criteria?\n\nThe patient is a 55-year-old man with Parkinson's disease, which meets the inclusion criterion of \"aged between 50 to 80 years (inclusive) at time of consent.\"\n\n#2: Does the patient meet the Hoehn-Yahr stage criteria?\n\nThe patient's Hoehn-Yahr stage is Stage I, which meets the inclusion criterion of \"Hoehn and Yahr stage between 1 and 3 (inclusive) in ON state.\"\n\n#3: Does the patient meet the cognitive impairment criteria?\n\nThe patient has mild cognitive impairment, which meets the inclusion criterion of \"diagnosis of PD-MCI according to MDS PD-MCI, Level I criteria.\"\n\n#4: Does the patient meet the duration of cognitive impairment criteria?\n\nThe patient has had cognitive impairment for at least 3 months, which meets the inclusion criterion of \"duration of cognitive impairment of at least 3 months (to distinguish from mild delirium).\"\n\n#5: Does the patient meet the exclusion criteria?\n\nThe patient does not have any of the exclusion criteria, such as insufficient fluency in English, severe visual or auditory impairment, or a history of deep brain stimulation or other neurosurgical procedure.\n\nBased on the above criteria, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: Eligible.",
    "PROBA": 0.93980365
  },
  {
    "ID": "5500_12-2021_NCT03975998",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Is the patient 18-75 years old?\n\nYes, the patient is 34 years old, which is within the age range of 18-75 years. Therefore, the patient meets the inclusion criterion of age.\n\n#2: Is the patient asymptomatic?\n\nNo, the patient is symptomatic, as she has a history of gestational diabetes mellitus, hypertension with pregnancy, and obesity. She also has a known severe mitral valve prolapse with regurgitation, which is causing her symptoms. Therefore, the patient does not meet the inclusion criterion of being asymptomatic.\n\n#3: Does the patient have severe organic mitral valve regurgitation?\n\nYes, the patient has severe organic mitral valve regurgitation, as determined by echocardiography. Therefore, the patient meets the inclusion criterion of severe organic mitral valve regurgitation.\n\n#4: Does the patient have preserved left ventricular function?\n\nYes, the patient has preserved left ventricular function, as her left ventricular ejection fraction is 65% and her left ventricular end-systolic dimension is <45 mm. Therefore, the patient meets the inclusion criterion of preserved left ventricular function.\n\n#5: Is the likelihood of MV repair more than 90%?\n\nYes, the likelihood of MV repair is more than 90%, as determined by the local heart team with a cardiologist and cardiothoracic surgeon. Therefore, the patient meets the inclusion criterion of likelihood of MV repair.\n\n#6: Does the patient have any exclusion criteria?\n\nYes, the patient has several exclusion criteria:\n\n* Pulmonary hypertension (>50 mmHg at rest)\n* Atrial fibrillation, either on 12-lead ECG or holter-monitoring\n* Physical inability as determined by the heart team to undergo surgery\n* Other life-threatening morbidity\n* Higher expected surgical risks in advance, according to the dedicated heart team\n* Patients with moderate to",
    "PROBA": 0.9587089244
  },
  {
    "ID": "35379_75-2021_NCT00824252",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient have Parkinson's disease?\n\n#2: Is the patient's disease stage mild (Hoehn-Yahr Stage I)?\n\n#3: Does the patient have hypertension and hypercholesterolemia?\n\n#4: Is the patient able to vocalize well enough to complete the spousal interaction task?\n\n#5: Does the patient have a spouse or significant other with whom he\/she resides?\n\n#6: Is the patient able to read and speak English?\n\n#7: Is the patient at least 18 years of age?\n\nPlease answer the questions with the following options:\n\nA: Yes\nB: No\nC: Not relevant\n\nLet me know when you are ready to proceed.",
    "PROBA": 0.8906065307
  },
  {
    "ID": "17300_36-2021_NCT03534024",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient have a body mass index (BMI) of 25 or greater?\n\n#2: Does the patient have a waist circumference of greater than 102 cm in men or 88 cm in women?\n\n#3: Does the patient have fasting blood glucose of greater than 100 mg\/dL?\n\n#4: Does the patient have triglycerides (TG) of greater than 150 mg\/dL?\n\n#5: Does the patient have high density lipoprotein cholesterol (HDL-C) of less than 50 in women or less than 40 in men?\n\n#6: Does the patient have systolic blood pressure (SBP) of greater than 130 mmHg or diastolic blood pressure (DBP) of greater than 85 mmHg?\n\nPlease answer the questions with either \"yes\" or \"no\" to determine if the patient is eligible for the clinical trial.",
    "PROBA": 0.9356960094
  },
  {
    "ID": "5402_12-2021_NCT02722551",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient have a severe mitral regurgitation?\n\nYes, the patient has severe mitral regurgitation.\n\n#2: Is the patient at high risk for open-heart surgery?\n\nYes, the patient has a history of gestational diabetes mellitus, hypertension during pregnancy, and obesity, which are all risk factors for open-heart surgery.\n\n#3: Does the patient meet the anatomical criteria for the study?\n\nYes, the patient has Marfan's syndrome and known severe mitral valve prolapse with regurgitation, which meet the anatomical criteria for the study.\n\n#4: Is the patient willing and able to undergo the study?\n\nYes, the patient is willing and able to undergo the study.\n\nBased on the information provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.",
    "PROBA": 0.9186980025
  },
  {
    "ID": "17117_36-2021_NCT02265185",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1. Does the patient meet the age criteria?\n\nYes, the patient is between 2 and 10 years old (inclusive), which meets the age criteria of 2 to 10 years old (inclusive).\n\n#2. Does the patient meet the ESI triage levels criteria?\n\nYes, the patient has an ESI triage level of 3-5, which meets the criteria of ESI triage levels 3-5.\n\n#3. Does the patient have a consenting parent or legal guardian?\n\nYes, the patient has a consenting parent, which meets the criteria of having a consenting parent or legal guardian.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.",
    "PROBA": 0.9130320929
  },
  {
    "ID": "14262_30-2021_NCT04333342",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient have Graves' disease?\n\nYes, the patient has been diagnosed with Graves' disease.\n\n#2: Is the patient currently being treated with anti-thyroid drugs (ATDs)?\n\nYes, the patient is currently being treated with ATDs.\n\n#3: Has the patient been on ATDs for more than 1 year?\n\nYes, the patient has been on ATDs for more than 1 year.\n\n#4: Does the patient have normal findings on thyroid function tests while maintaining stable doses of ATDs in the last 3 months?\n\nYes, the patient's thyroid function tests have been normal while maintaining stable doses of ATDs in the last 3 months.\n\n#5: Is the patient willing and able to use wearable devices and smartphone apps during the research period?\n\nYes, the patient is willing and able to use wearable devices and smartphone apps during the research period.\n\nBased on the answers to these questions, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: Eligible.",
    "PROBA": 0.9430602554
  },
  {
    "ID": "16942_36-2021_NCT00709501",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "The patient is a 32-year-old obese woman with a BMI of 41.54, which is well above the inclusion criteria of BMI 27-40 kg\/m2. Therefore, the patient is not eligible based on this criterion.\n\nThe patient is also not eligible based on the exclusion criteria of recent weight loss of >= 15 lbs in the past 6 months, as she has not lost any weight recently.\n\nHowever, the patient does meet the other inclusion criteria of being fluent in English, having access to the internet, and agreeing not to seek additional weight loss treatment.\n\nTherefore, based on the provided information, the patient is not eligible for the clinical trial.\n\nSo, the patient is \"excluded\" from the clinical trial.",
    "PROBA": 0.9105645855
  },
  {
    "ID": "6869_15-2021_NCT02773563",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient meet the inclusion criteria?\n\n#2: Does the patient meet the exclusion criteria?\n\nPlease select one of the following options:\n\nA: Eligible\nB: Excluded\nC: Irrelevant\n\nPlease provide your answer.",
    "PROBA": 0.828606071
  },
  {
    "ID": "17049_36-2021_NCT01640015",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient meet the age criteria?\n\n#2: Does the patient meet the BMI criteria?\n\n#3: Does the patient meet the smoking criteria?\n\n#4: Does the patient meet the alcohol criteria?\n\n#5: Does the patient meet the pregnancy criteria?\n\n#6: Does the patient meet the medical history criteria?\n\n#7: Does the patient meet the medication criteria?\n\nPlease answer each question with either \"yes\" or \"no\" and I will determine the patient's eligibility based on your answers.",
    "PROBA": 0.8724788214
  },
  {
    "ID": "35797_75-2021_NCT04568005",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient have primary or secondary lymphedema?\n\n#2: Is the patient's stage I, II, or III?\n\n#3: Does the patient have upper or lower extremity lymphedema?\n\nPlease answer each question with either \"yes\" or \"no\" before moving on to the next question.",
    "PROBA": 0.8532542821
  },
  {
    "ID": "17190_36-2021_NCT02751307",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "import { INCLUSION_CRITERIA, EXCLUSION_CRITERIA } from '.\/constants';\n\nconst patientNote = {\n  age: 32,\n  gender: 'female',\n  height: 165,\n  weight: 113,\n  BMI: 41.54,\n  sleepApnea: true,\n  PCO: true,\n  dissatisfactionWithBodyShape: true,\n  maritalStatus: 'married',\n  occupation: 'high-school teacher',\n  priorPregnancies: false,\n  smoking: false,\n  drugUse: false,\n  fourSquareStepTest: {\n    seconds: 14,\n  },\n  bloodPressure: {\n    systolic: 130,\n    diastolic: 80,\n  },\n  heartRate: 195,\n  labs: {\n    FBS: 98,\n    TG: 150,\n    Cholesterol: 180,\n    LDL: 90,\n    HDL: 35,\n  },\n  cardiacAssessment: {\n    normal: true,\n  },\n  jointsAndROM: {\n    normal: true,\n  },\n};\n\nconst clinicalTrial = {\n  title: 'Adjunctive Low-dose Metformin in Patients With Schizophrenia and Metabolic Abnormalities',\n  summary: 'Metformin has been used for alleviating metabolic abnormalities in patients with schizophrenia. Until now, the lowest dose of metformin to treat metabolic abnormalities in clozapine-treated patients is 1000 mg\/d. The aim of this study was to determine whether a lower dosage of metformin, such as 500 mg\/d, is effective for improving metabolic profiles in clozapine-treated patients with pre-existing metabolic abnormalities.',\n  interventionType: 'Drug',\n  inclusionCriteria: [\n    {",
    "PROBA": 0.9693589341
  },
  {
    "ID": "17051_36-2021_NCT01665547",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1. Does the patient meet the inclusion criteria?\n\n#2. Does the patient meet the exclusion criteria?\n\nPlease select one of the options in the bracket at the end of each question to indicate your answer.\n\nThank you!",
    "PROBA": 0.7578103738
  },
  {
    "ID": "17095_36-2021_NCT02024360",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient meet the inclusion criteria?\n\n#2: Does the patient meet the exclusion criteria?\n\nPlease select one of the following options based on your evaluation:\n\nA: Eligible\nB: Excluded\nC: Irrelevant\n\nPlease provide your answer.",
    "PROBA": 0.8340090112
  },
  {
    "ID": "6894_15-2021_NCT02984501",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1. Does the patient have pancreatic ductal adenocarcinoma?\n\nYes, the patient has a diagnosis of pancreatic adenocarcinoma based on the biopsy results.\n\n#2. Is the patient's tumor borderline resectable or unresectable?\n\nYes, the patient's tumor is unresectable based on the CT scan results.\n\n#3. Has the patient received previous radiochemotherapy to the abdomen?\n\nNo, the patient has not received previous radiochemotherapy to the abdomen.\n\n#4. Is the patient between 18 and 75 years old?\n\nYes, the patient is 70 years old, which is within the inclusion criteria age range of 18 to 75 years.\n\n#5. Does the patient have adequate cardiac, liver, and kidney function, and a good bone marrow reserve?\n\nThe patient's recent laboratory results show adequate cardiac, liver, and kidney function, and a good bone marrow reserve.\n\nBased on the above criteria, the patient is eligible for the clinical trial.\n\nTherefore, the answer is:\n\nA. Eligible",
    "PROBA": 0.9190290081
  },
  {
    "ID": "24931_53-2021_NCT00160264",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient meet the inclusion criteria?\n\n#2: Does the patient meet the exclusion criteria?\n\nPlease select one of the options in the bracket at the end of each question.\n\nThank you!",
    "PROBA": 0.7802848241
  },
  {
    "ID": "17409_36-2021_NCT04548102",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient meet the inclusion criteria?\n\nYes, the patient meets the inclusion criteria of being a second gravida with a singleton pregnancy at 28 weeks gestation.\n\n#2: Does the patient have any of the exclusion criteria?\n\nNo, the patient does not have any of the exclusion criteria such as history of psychological problems, drug abuse, experience of terrible life events during the past 6 months, oligohydramnios, multi-fetal pregnancy, or fetal abnormalities.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.",
    "PROBA": 0.9194068124
  },
  {
    "ID": "17181_36-2021_NCT02706262",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient meet the inclusion criteria?\n\nThe patient does not meet the inclusion criteria because she is not metabolically normal. Her BMI is 41.54, which is above the upper limit of 30.0 for obese subjects. Additionally, her fasting plasma glucose concentration is 98 mg\/dl, which is above the upper limit of 100 mg\/dl for metabolically normal subjects. Therefore, the patient does not meet the inclusion criteria.\n\n#2: Does the patient meet the exclusion criteria?\n\nThe patient does not meet the exclusion criteria. She does not have any of the conditions listed, such as medical, surgical, or biological menopause, previous bariatric surgery, or significant organ system dysfunction. Additionally, she does not smoke, use marijuana, or consume excessive alcohol. She is also not taking any medications that would affect the study outcome measures or increase the risk of study procedures. Therefore, the patient does not meet the exclusion criteria.\n\nBased on the above analysis, the patient is not eligible for the clinical trial.\n\nSo, the patient is \"excluded\" from the clinical trial.",
    "PROBA": 0.9114504055
  },
  {
    "ID": "14189_30-2021_NCT03568370",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient have a normal spontaneous delivery?\n\nNo, the patient had a cesarean section. Therefore, she does not meet the inclusion criterion.\n\n#2: Is the patient's pregnancy between 37-42 weeks?\n\nNo, the patient's pregnancy was at 33 weeks. Therefore, she does not meet the inclusion criterion.\n\n#3: Is the patient having a single birth?\n\nYes, the patient had a single birth. Therefore, she meets the inclusion criterion.\n\n#4: Has the patient initiated breastfeeding?\n\nYes, the patient has initiated breastfeeding. Therefore, she meets the inclusion criterion.\n\n#5: Does the patient have any exclusion criteria?\n\nYes, the patient has an exclusion criterion of having a cesarean section.\n\nBased on the above criteria, the patient is not eligible for the clinical trial.\n\nSo, the patient is \"excluded\" from the clinical trial.",
    "PROBA": 0.9198953588
  },
  {
    "ID": "6776_15-2021_NCT01966081",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Age\n\nThe patient is 70 years old, which is within the inclusion criteria age range of \u2265 45 years. Therefore, the patient meets the age criterion.\n\n#2: Diagnosis\n\nThe patient has been diagnosed with pancreatic adenocarcinoma, which is an eligible condition for the clinical trial.\n\n#3: Treatment\n\nThe patient has been treated with IV antibiotics (Zosyn, then ceftriaxone and flagyl) and will continue on them until seen by ID as an outpatient. This treatment is not excluded in the clinical trial, and the patient is eligible to continue with the treatment during the study.\n\n#4: Other Exclusion Criteria\n\nThe patient does not have any of the exclusion criteria listed, such as pre-operative anticancer treatment, existence of visceral metastases, familial adenomatous polyposis, or known inflammatory disease of the intestine.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.",
    "PROBA": 0.9161718078
  },
  {
    "ID": "14197_30-2021_NCT03641638",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient have a first pregnancy between the ages of 18 to 35 years old?\n\nYes, the patient has a first pregnancy between the ages of 18 to 35 years old.\n\n#2: Does the patient have normal thyroid function (FT3, FT4, TSH) and antibodies in early pregnancy (1-12 weeks)?\n\nNo, the patient has high levels of TPOAb and normal thyroid function (FT3, FT4, TSH).\n\n#3: Is the patient in the observation group (TPOAb positive and thyroid function normal) or the control group (TPOAb negative and thyroid function normal)?\n\nThe patient is in the observation group (TPOAb positive and thyroid function normal).\n\n#4: Does the patient meet any exclusion criteria?\n\nNo, the patient does not meet any exclusion criteria.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.",
    "PROBA": 0.9176616879
  },
  {
    "ID": "7038_15-2021_NCT04279821",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient have colonic diverticulosis?\n\nYes, the patient has a history of colonic diverticulosis, as evidenced by the CT abdomen without contrast showing a large 9.5 x 7.5 x 6.0-cm heterogeneous left upper abdominal mass.\n\n#2: Does the patient have macroscopic signs of inflammation (erythema, friability, and ulcerations) of the interdiverticular mucosa?\n\nNo, the patient does not have macroscopic signs of inflammation (erythema, friability, and ulcerations) of the interdiverticular mucosa. The patient has a history of abdominal pain, radiating to the left flank, and vomiting, but there is no mention of erythema, friability, or ulcerations.\n\n#3: Is the patient willing and able to sign informed consent?\n\nYes, the patient is willing and able to sign informed consent, as evidenced by the fact that they have been treated with IV antibiotics and will continue on them until seen by ID as an outpatient.\n\n#4: Does the patient have any exclusion criteria?\n\nYes, the patient has an exclusion criterion of diagnosis of chronic inflammatory bowel disease, as evidenced by the patient's history of mitral valve prolapse, atrial fibrillation, hyperlipemia, hypertension, chronic kidney disease, hypothyroidism, and anemia.\n\nBased on the above, the patient is not eligible for the clinical trial.",
    "PROBA": 0.9333029403
  },
  {
    "ID": "5381_12-2021_NCT02474108",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient have a rheumatic mitral valve lesion?\n\n#2: Does the patient have a history of atrial fibrillation?\n\n#3: Is the patient's left atrium size greater than 6.0 cm?\n\nPlease answer each question with either \"yes\" or \"no\" before moving on to the next question.",
    "PROBA": 0.8576228381
  },
  {
    "ID": "35392_75-2021_NCT00955045",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1. Does the patient have Parkinson's disease?\n\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2. Is the patient at least 30 years old?\n\nYes, the patient is 55 years old, which is greater than 30.\n\n#3. Has the patient completed participation in a prior double-blind istradefylline trial?\n\nNo, the patient has not participated in a prior double-blind istradefylline trial.\n\n#4. Does the patient meet the UKPDS brain bank criteria for Parkinson's disease?\n\nYes, the patient meets the UKPDS brain bank criteria for Parkinson's disease.\n\n#5. Has the patient been treated with levodopa for at least 1 year?\n\nYes, the patient has been treated with levodopa for at least 1 year.\n\n#6. Is the patient currently taking at least 4 doses of levodopa per day?\n\nYes, the patient is currently taking at least 4 doses of levodopa per day.\n\n#7. Does the patient have predictable end-of-dose wearing-off?\n\nYes, the patient has predictable end-of-dose wearing-off.\n\nBased on the criteria, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: Eligible.",
    "PROBA": 0.95277082
  },
  {
    "ID": "14009_30-2021_NCT01341886",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient have papillary or follicular thyroid cancer?\n\nYes, the patient has papillary thyroid cancer.\n\n#2: Is the patient's cancer stage 1 or 2 according to TNM system version 6?\n\nYes, the patient's cancer stage is 1.\n\n#3: Has the patient undergone surgery and radioiodine treatment?\n\nYes, the patient has undergone surgery and radioiodine treatment.\n\n#4: Is the patient currently receiving levothyroxine suppression treatment?\n\nYes, the patient is currently receiving levothyroxine suppression treatment.\n\n#5: Does the patient have any exclusion criteria?\n\nNo, the patient does not have any exclusion criteria.\n\nTherefore, based on the inclusion and exclusion criteria, the patient is eligible for the clinical trial.",
    "PROBA": 0.9296822656
  },
  {
    "ID": "30833_65-2021_NCT03179280",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient have type 1 diabetes?\n\nYes, the patient has type 1 diabetes, confirmed with molecular analysis 7 years ago.\n\n#2: Is the patient's duration of diabetes >3 years?\n\nYes, the patient has had diabetes for >3 years.\n\n#3: Is the patient on CSII therapy for at least 1 year?\n\nYes, the patient is on CSII therapy.\n\n#4: Does the patient have good to moderate glycaemic control, as evidenced by HbA1c levels <8.5% (69 mmol\/mol)?\n\nYes, the patient's HbA1c level is 6.5%, which is within the acceptable range.\n\nTherefore, based on the inclusion and exclusion criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.",
    "PROBA": 0.9283346831
  },
  {
    "ID": "35747_75-2021_NCT04165278",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient meet the inclusion criteria?\n\nThe patient is a 55-year-old man with Parkinson's disease, which meets the inclusion criterion of having a diagnosis of Idiopathic Parkinson's Disease (IPD) based on the Movement Disorder Society clinical diagnostic criteria for Parkinson's Disease.\n\n#2: Does the patient have a subjective feeling that their Motor Symptoms (MS) of Parkinson's Disease (PD) were affected by seasonal variation and improved after Hyperthermic Baths (HTB)?\n\nYes, the patient reports that their MS were more severe in winter than in summer and improved after HTB, which meets the inclusion criterion of having a subjective feeling that MS were affected by seasonal variation and improved after HTB.\n\n#3: Is the patient willing to comply with the study requirements and does not have any exclusion criteria?\n\nYes, the patient is willing to comply with the study requirements and does not have any of the exclusion criteria, such as symptomatic bradycardia, severe postural hypotension, symptomatic coronary insufficiency, severe organic heart damage, severe cerebrovascular disease, active psychosis, dementia (Mini-Mental State Examination (MMSE) < 24 and Montreal Cognitive Assessment (MOCA) < 26), or failure to cooperate with the study requirements and poor compliance.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.",
    "PROBA": 0.9481693885
  },
  {
    "ID": "17125_36-2021_NCT02375113",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Age\nThe patient is 32 years old, which is within the inclusion criteria age range of 45-60 years old. Therefore, the patient meets the age inclusion criterion.\n\n#2: Menopausal status\nThe patient is peri-menopausal, which is within the inclusion criteria of experiencing irregular menses along with one or more other symptoms of menopause. Therefore, the patient meets the menopausal status inclusion criterion.\n\n#3: BMI\nThe patient has a BMI of 41.54, which is greater than the inclusion criteria of BMI > 25. Therefore, the patient meets the BMI inclusion criterion.\n\n#4: Waist circumference\nThe patient's waist circumference is not specified in the patient note, but based on the BMI, it is likely that the patient's waist circumference is also greater than the inclusion criteria of > 88 cm. Therefore, the patient likely meets the waist circumference inclusion criterion.\n\n#5: Ability to understand and comply with study procedures\nThe patient note does not provide information about the patient's ability to understand and comply with study procedures. However, based on the patient's ability to complete the four square step test and the physical examination, it can be assumed that the patient has the ability to understand and comply with study procedures.\n\n#6: Exclusion criteria\nThe patient note does not mention any history of cancer, tumors in the reproductive system, allergies to soy or milk protein, known metabolic disorders, hormone replacement therapy, or recent use of medications that may affect body weight and body composition. Therefore, the patient does not meet any of the exclusion criteria.\n\nBased on the above assessment, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: Eligible",
    "PROBA": 0.9314509959
  },
  {
    "ID": "17338_36-2021_NCT03972059",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1. Does the patient meet the inclusion criteria?\n\nYes, the patient meets the inclusion criteria of being overweight (BMI: 25-35 kg\/m^2) and having a sedentary lifestyle.\n\n#2. Does the patient meet the exclusion criteria?\n\nNo, the patient does not meet the exclusion criteria of having a family history of coronary heart disease or recent musculoskeletal injury.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.",
    "PROBA": 0.9200500453
  },
  {
    "ID": "24995_53-2021_NCT00742235",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Age\nThe patient is 34 years old, which is within the inclusion criteria age range of 18-80. Therefore, the patient meets the age criterion.\n\n#2: Known active infectious disease or chronic inflammatory disorder\nThe patient does not have any known active infectious disease or chronic inflammatory disorder, which is an exclusion criterion. Therefore, the patient does not meet this criterion.\n\n#3: Hypercalcemia\nThe patient's laboratory results do not show any evidence of hypercalcemia, which is an exclusion criterion. Therefore, the patient does not meet this criterion.\n\n#4: Chronic kidney disease\nThe patient's laboratory results do not show any evidence of chronic kidney disease, which is an exclusion criterion. Therefore, the patient does not meet this criterion.\n\n#5: Pregnancy\nThe patient is not pregnant, which is an exclusion criterion. Therefore, the patient meets this criterion.\n\nBased on the above evaluation, the patient is eligible for the clinical trial. Therefore, the answer is [A] eligible.",
    "PROBA": 0.9385421319
  },
  {
    "ID": "30811_65-2021_NCT02893306",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient have Type 1 Diabetes?\n\nYes, the patient has been diagnosed with Type 1 Diabetes, so this criterion is met.\n\n#2: Was the diagnosis performed within the past year?\n\nYes, the diagnosis was performed within the past year, so this criterion is also met.\n\n#3: Does the patient have a pancreatic reserve of insulin higher than 0.8 nmol\/L\/h?\n\nThe patient's lab results show a pancreatic reserve of insulin of 1.2 nmol\/L\/h, which is higher than the inclusion criterion of 0.8 nmol\/L\/h. Therefore, this criterion is met.\n\n#4: Is the patient in good general health status?\n\nYes, the patient is in good general health status, as there is no mention of any significant comorbidities in the patient note. Therefore, this criterion is met.\n\n#5: Has the patient provided informed consent?\n\nYes, the patient has provided informed consent, as indicated in the patient note. Therefore, this criterion is met.\n\n#6: Has the treating physician provided consent?\n\nYes, the treating physician has provided consent, as indicated in the patient note. Therefore, this criterion is met.\n\n#7: Does the patient have proved psychiatric competence to be enrolled in a clinical study?\n\nThere is no mention of any psychiatric issues or competence in the patient note, so it can be assumed that the patient has proved psychiatric competence. Therefore, this criterion is met.\n\nBased on the above criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.",
    "PROBA": 0.9365684539
  },
  {
    "ID": "17217_36-2021_NCT03011294",
    "TOPIC_YEAR": 2021,
    "RESPONSE": "#1: Does the patient have moderate to severe OSA?\n\n#2: Is the patient a bed partner of a patient with moderate to severe OSA?\n\n#3: Is the patient willing and able to use the study device (nasal CPAP or nasal strips) for 3 months?\n\n#4: Does the patient have any exclusion criteria (e.g. OSA using specific treatment)?\n\nPlease answer the questions with the following options:\n\nA: Eligible\nB: Excluded\nC: Irrelevant\n\nPlease provide your answer for each question.",
    "PROBA": 0.851523678
  }
]
